AMARIN $6.60

down -0.02


18/6/2013 04:18 PM  |  NASDAQ : AMRN  |  Industries : Manufacturing / Pharmaceutical and Medicine Manufacturing
Quotes displayed are delayed by 15 minutes. Market data is provided by Telvent DTN
Get Trend Analysis Icon Get AMRN Trend Analysis - it has underperformed the S&P 500 by 68%

ETF Alternatives

Ticker Name Weight % Change
IBB ISHARES NASDAQ BIOTECHNOLOGY 0.27% +1.35%


People viewing AMRN also viewed: , , , ,

Competitors

Ticker Name Volume % Change
RXEI RXELITE 45.2K +4.00%
ALSE ALSERES PHARMACEUTICALS 600.0 +1.00%
ALLP ALLIANCE PHARMACEUTICAL 3.5K +0.82%
KVPBQ K-V PHARMACEUTICAL 1.4K +0.82%
HRDN DC BRANDS INTERNATIONAL INC. C 16.7M +0.67%

AMRN Stock Analysis

  1. AstraZeneca Looks To Fish Oil To Round Out Its Cardio Portfolio

    AstraZeneca validates the purified fish oil concept, but not at an especially high price.
  2. Another Negative Fish Oil Study Adds To Amarin's Marketing Challenges

    More questions about the real efficacy of fish oil is bad news for Amarin.
Free Reports
  1. 21-page Book on Learning to Trade Options on Futures!

    Not too complex. Not too basic. Just enough information to help you ask the right questions so you can start using these markets.
  2. Get 10 Trading Lessons FREE

    Benefit from the knowledge of MarketClub co-founder Adam Hewison and our other trading experts, with this FREE series of educational emails and online content.
  3. 4 Best Buy ETFs for the Current Market

    Don't miss this FREE Special Report from Forbes' fund and ETF expert Jim Lowell.
Marketplace
Trading Center